|
Nutritional and therapeutic benefits |
 |
|
POTENTIAL REDUCTION IN RISK OR IMPACT |
| |
|
| All cause mortality, sudden cardiac death, ischemie stroke, triglyceride reduction (especially DHA), possible HDL increase but generally doesnot impact overall lipid levels in low-to-moderate amounts (large intakes from supplements can significantly reduce triglycerides), bloodpressure and heart rate reduction. |
|
|
|
|
| Colorectal cancer, inflammatory bowel disease (Crohn disease and ulcerative colitis). |
|
Immunology/infectious disease/nephrology |
|
| Asthma, hepatitis, IgA nephropathy. |
|
|
| Alzheimer’s disease (especially DHA), dementia, autism, attention deficit-hyperactivity disorder. |
|
|
| Maternal and child health (especially DHA), cognitive (improved intelligence quotient) and visual impact in newborns and adolescents, improves gestation length, size, and potentially a variety of other outcomes, such as postpartum depression. |
|
|
| Breast cancer, cachexia (reduces weight loss), colorectal cancer, endometrial cancer, leukaemia, melanoma, ovarian cancer, pancreatic cancer,prostate cancer, renal cell cancer, DHA-paclitaxel combination drug in phase I/II trials, and may improve the impact of other standard chemotherapy drugs (5-fluorouracil, cyclophosphamide) from laboratory studies. |
|
|
| Macular degeneration, retinitis pigmentosa. |
|
|
| Osteoporosis/fracture, inflammatory/joint conditions (arthritis). |
|
|
| Depression, bipolar disorder, schizophrenia, attention deficit-hyperactivity disorder. |
|
|
| Rheumatoid arthritis, osteoarthritis, osteoporosis. |
|
|
| Improve postoperative healing and other outcomes but may also cause unwant blood thinning if supplements taken preoperatively. |
|
|
| Prostate cancer, prostatitis, benign prostatic hyperplasia. |
|
|
+34 932 170 366